Compared with nonpregnant patients with AIS treated with MT , they experienced lower rates of intracranial hemorrhage ( 0.11 versus 0.24 , P = 0.069 ) and poor functional outcome ( 0.5 versus 0.72 , P = 0.003 ) at discharge .